Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Anything that happened AFTER Sept 30 will not be in the 10-Q, so DL and events surrounding DL has nothing to do with the delay of filing 10-Q. They stated that the acquisition of Flaskworks and the finances involved were the reason they could not get it done in time.
Please be careful when reading. It doesn't said it will be manufactured in Cambridge, but that the company who will manufacture it, is from Cambridge.
BSB, love your posts, but there's no way there will be a buy out before approval. They could discuss certain parameters and enter into a JV, that could lead to a BO, but a straight BO before Approval is highly unlikely.
Time to go show the young golf pros here in Vegas that old people can take their money.
Hope all your dreams come true (sooner or later).
Patience is a virtue that is definitely tested as a shareholder in NWBO.
I agree that (Hopefully) have lined up a narrative that will keep them going after TLD. They have had time to create their 'story' to maximize the effect of TLD and other news. I know this is hard for the long time shareholders, but I have full faith in LP. Everything that happened prior to DL, is in the past. She is a seasoned CEO and have hopefully used her vast resources to make sure she will roll this out the right way.
They are human beings with normal personal traits like vanity, narcicism etc.
I am fully stocked, thanks. 100% of my Roth at $0.54 and probably too high a percentage of my regular portfolio at $0.57. Both averaged up from the first ride up.
I am not worried about anything short term, as I am holding on for the full ride to commercialization. With the two weekends extended their 5 day extension, I am of the belief they will file the 10-Q Monday. Releasing TLD before or at the same time is usually not what companies will do in this situation. They normally let the market absorb the 10-Q and then release TLD. 10-Q's in pre revenue biotech is normally not that influential on SP, but there is no need to have that potential negative AFTER TLD. Once they release TLD, they should be in control to tell their story with as few road bumps as possible.
You are entitled to your opinion, but they will not release TLD until at least a day or two after they file the 10-Q. 10-Q hopefully Monday and TLD the week following Thanksgiving is my guess, if they are ready at that time to tell 'their story'.
Please tell me why LP should mention another trials FDA communications? I understand how people in here think that the SP will fly if they change the cinicaltrial.gov, but WHY would you tempt your faith with the FDA until you have a direct message from them which would come from their approval meeting? The FDA have proven time and time again that they are thin skinned and even though it might be helpful to investors short term, I just don't see any reason to tempt the faith with a 'clerical' change.
We might see a joint venture, in the case our company feels we are better suited with some muscle behind the approval process and launch.
There will not be a buy-out before RA approval. No BP would pay a fortune with a risk of FDA approval hanging over their head. They might have had informal discussion regarding a deal after RA approval, but we will not know anything about that until announced after approval.
I wish life was that easy, I truly do, but there's a lot of things that need to happen until we get to a BO.
Monday, and only things directly having an effect on last quarters financials will be required to be included in 10-Q.
You are arguing that. You focus on multiple of SP vs value to the acquiring company.
We all are, but in the event that is not imminent, there's ways to improve value to shareholders in the short term.
Good Night and lets hope whatever happens, it will be great for Patients and Longs.
Did they do it to uplist and attract institutional investors in a period when the SP was going up? Or did they do it in a downturn trying to avoid delisting?
There's a big difference in why you do a RS and how that is communicated to shareholders. If done right, it can actually increase the SP drastically.
Just uplisting at a price under $5, will not move the SP. Doing it alongside a RS, will open up the stock to institutional investors and hedge fund, who have investment strategies that won't allow them to invest in companies with a SP under a certain value.
Granted, we could see a $5+ SP after TLD, but staying on OTC will not prevent MM's and shorts from continuing their attacks and that can bring the SP back down in a hurry, regardless of how much we know it should be a lot higher. We will not have the cover of a major exchange, institutional investors and Hedge funds.
If you are happy with a small profit post TLD, then we should stay here in Penny land.
Not sure where you get your information, but RS is only bad if done to remain listed, which is the majority of the times RS is used as a tool In most other situations, it is a positive, as when done in connection with an uplisting. It opens the door to institutional investors, who otherwise would not be able to buy due to their investment strategies. But you are entitled to your opinion
Haha. It's not always a bad scenario. If done in connection with an uplisting, it's usually a successful move. RS for the sake of increasing SP, without an immediate uplisting is not a positive.
You got me 2-1, but in my own experience, the fact that there will be much less outside noise on one of the major exchanges as opposed to OTC, would make for a much smoother ride. I think for timing purposes, if they have plans to uplist, they should do a RS and uplist before TLD. I know how people view RS's, but I just think in this situation, combined with an uplisting, it would be a positive.
I know LP has said in the past that she would prefer uplisting to NYSE instead of NASDAQ. Now that we are in position to apply to get uplisted on NASDAQ, do you think that could be, speculating of course, one of the reasons for the delay of TLD? Do you think it could be another reason to extend the warrants? Would the response to positive TLD be better received on NASDAQ vs. OTC?
I hate these speculative posts, but I have not seen any recent discussions on the uplisting subject.
I am not saying it has anything to do with the 5 day extension of the 10-Q, as I am of the conviction that we are not late.
You could very well be right. Warrant holders not taking any chances before locking in a profit and Shorts preparing for the first drop after TLD. I doubt anyone serious about investing are simply looking for shares to short at this level.
Agree 100% that most of the shorting are warrant holders locking in a profit on some or all of their warrants.
The various financial selections regarding the acquisition of Flaskworks. That's it,. Nothing interesting and absolutely nothing in regard to TLD, as DL came after the quarter ended. There could be information about production agreements and Sawston as they relates to the finances, but that is very minor.
LOL, when quarter ends at 9/30, you need to include October in the 45 days. That gives you November 14th. My only mistake was not realizing that is a Saturday.
As October have 31 days, the 45 days deadline is Nov. 14th, so 5 added calendar days will make the extension deadline Nov. 19th, which is Thursday. I do not know, nor care if they release the 10-Q by then as I have been told by reliable sources that as long as you file the extension, they are not particular in when you actually file, due to Covid-19.
Most of these can be outsourced either to companies specializing in that area or via a joint venture with a company that has the support mechanisms in place for full commercialization. I am not saying that they won't seek a buy-out. Buy-out seems most likely considering the age of the key personnel of the company, but it is not like they couldn't take it to the market by themselves. LP has continuously said she wants DCVax to get to the patients, so she will be careful in selecting a dance partner.
I think this will be a huge success long term, but BO is in my humble opinion not on the immediate horizon. I think they will have lots of good news coming up, in a carefully orchestrated manner. They can create their own narrative starting with release of the TLD. People who worry about warrants, are thinking short term. In the long picture (next 12-24 months) they mean absolutely nothing.
The eternal predictions of where the daily SP will go, is also completely irrelevant unless you are trading in the stock.
The release of the 10-Q will happen when they are ready. They filed the extension and in the time of a pandemic they will not have to worry about when they release it. This company is a pre-revenue biotech and as such, very little in the financial section will be relevant 6 months from now. They might add some info about agreements entered into during the last quarter, that will have an influence in going forward, such as agreements with Cognate, Advent etc. They might also include some info about Sawston and the completion status of phase I. Though these are interesting news for those of us who follow the company closely, they are likely absolutely insignificant in their influence on the short term SP.
I can see a lot of you are looking for little events that you feel should move the SP up, but unless more investors show up with big bags of money, we are going to trade sideways until TLD, with some days with upswing and some days with downswings. I personally think TLD could come any day, but in the overall picture the timing is not important. What is important is that LP et al. don't hurry it and takes their time, so they can deliver the best possible timeline for the patients, the company and us investors.
There was not.
Free Druggie!!!
Glad to be helping you out......
It says 'Calendar days' on SEC website. There will be no penalties from missing the deadline as long as you filed the extension, due to Covid-19.
Stay away from the toppings.....complete rip-off
Don't think we can really count on that. Covid-19 has made it seemingly acceptable to delay 10-Q's even past the extension deadline, as long as you file for an extension in the first place.
Why would they come out and tell us about their deal with the SEC and if they are allowed an extension beyond the five calendar days? Every time they make a statement to the public in writing (and should also be for other communications, they need to consult their lawyers (I know some of them have legal degrees, but that doesn't make them experts in SEC communications.)
NWBO have a compliance officer per the deal they have previously made with the SEC. As such, there are communications between him and SEC, which should result in an approved delay in addition to the 5 calendar days.
Don't get your hopes up too high that we will see a 10-Q in the near future. Last time they filed for an extension, it took them 5 weeks to release to form.
I am curious who you think are snowflakes. The longs here, the shorts here or one of the political sides. Please enlighten me.
Hope you are right. Georgia Voting System implementation manager just said the 20. on TV.
This is my last post as a freeloader, going to watch some football and enjoy the last couple of days of steady climb. Hope there's nothing surprising in the 10-Q tomorrow that will influence the SP too drastically.
After market have absorbed the 10-Q, we should be ready for TLD. Tuesday-Thursday next week is my betting choice.
Second day we end near session highs, which is a great sign.
My family hates them too, PM. Good thing is that I know when I bring them back, they won't eat them.
poppy seed with just butter for me, so your version is the deluxe meal....
So bagels are not a full meal? It counts in my book.
Should touch on all 3, at least in terms of their relationship to budget/expenses, but maybe it will discuss them going forward too.